News

The Argentine has become a close ally of the Trump administration, including on health policy. Argentina has followed the U.S ...
Unlike traditional dry eye therapies, Tixel irequires no downtime. The entire treatment takes only two minutes, and patients ...
Aldeyra had received 2 complete response letters (CRL) from the FDA in April 2025 and November 2023 for past submissions.
A panelist discusses how the COAT trial demonstrated that twice-daily 0.09% cyclosporine improves multiple signs and symptoms ...
Washington University researchers found that raising a molecule called ApoM helps eye cells sweep away harmful cholesterol ...
Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...
A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...
A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related ...
With overall syphilis rates on the rise, serologic testing for syphilis in patients with uveitis can help prevent permanent vision damage.
Phase 2 results were positive for ILYX-002, a topical immunomodulator for moderate to severe dry eye disease associated with systemic autoimmune or inflammatory conditions, according to a press ...
Dry eye continues to be a hot spot when it comes to new diagnostic and therapeutic modalities.Large established companies and ...
Topline data were announced from a phase 3 trial evaluating ST-100 ophthalmic solution for the treatment of dry eye disease.